TYENNE

Subcutaneous biosimilar medications for patient self-administration

COMMERCIAL BRAND
TYENNE

ACTIVE PRINCIPLE
TOCILIZUMAB

TYPE OF DEVICE
PRE-FILLED PEN

LATEX
DO NOT

TEMPERING TIME
45 minutes

START OF INJECTION
Pressing against the skin

CLICK TO THE START (IN PEN)
YES

CLICK AT THE END (IN PEN)
YES

BioSim Newsletter

Subscribe to receive a weekly summary of current events on biosimilar medicines in your email.

PRIVACY POLICY

SUBSCRIBE